We are passionate about our purpose, we are committed to each other and we act as one team with a heightened sense of urgency.   We plan to employ our validated TPE® technology to expand our pipeline of oral therapeutic options for patients with rare diseases to use in place of painful and burdensome injections.

Learn more about

Our Platform Technology

Our Research

Patients & Families We Serve

Our Values

We never give up. Resiliency is in our DNA.

We love what we do, and we achieve results that matter for patients, for investors and for ourselves.

We are clever and resourceful in how we identify and execute on meaningful opportunities.

Our commitment to patients is unwavering. The only way we can succeed is to be committed to each other in achieving our purpose.

Diseases progress and our patients cannot wait. This is what drives every activity within our organization to bring innovations to market as fast as we can.

Our Values

Persistence

We leverage our resiliency in the face of challenges to pursue our mission.

Passion for Results

We embed integrity and energy in all we do to achieve superior results built on a foundation for sustainable and profitable growth.

Ingenuity

We utilize our innovative technology to develop novel solutions that address significant unmet medical needs.

Commitment to People

We focus on the impact of our actions and are responsible to patients, our community and our people.

Sense of Urgency

We act with speed, efficiency and accountability to benefit patients, employees, and shareholders.

Management Team

Chiasma’s team has the diverse development and commercialization expertise needed to advance oral therapies to help patients with rare diseases overcome the everyday challenges associated with existing injectable therapies.

Raj Kannan

Raj Kannan

Chief Executive Officer
Mark Fitzpatrick

Mark J. Fitzpatrick

President
William Ludlam

William Ludlam, M.D., Ph.D.

Senior VP Clinical Development and Medical Affairs
Anand Varadan

Anand Varadan

Chief Commercial Officer
Drew Enamait

Drew Enamait

VP Finance & Administration
Lee Giguere

Lee Giguere

VP General Counsel
Shoshie Katz

Shoshie Katz

VP Quality Assurance & Regulatory Affairs
Gary Patou

Gary Patou, M.D.

Head of Clinical

Board of Directors

Dave Stack

Chairman of the Board

Raj Kannan

CEO and Director

Todd Foley

Director

Bard Geesaman, M.D., Ph.D.

Director

Roni Mamluk, Ph.D.

Director

Scott Minick

Director

John A. Scarlett, M.D.

Director

John F. Thero

Director